Sale!

Anti-DBH Saporin Conjugate

Original price was: $148.00.Current price is: $37.00.

SKU: PW14836859381 Category:

Description

Anti-DBH Saporin Conjugate

Catalog number: B2024588
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 25 ug
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-DBH-SAP synonyms: Anti-Dipeptidyl Peptidase IV, Dipeptidyl Peptidase IV Inhibitor, DPP-IV Inhibitor, Anti-DPP-IV, DBH-SAP Inhibitor, Anti-Dipeptidyl Peptidase, Dipeptidyl Peptidase Antagonist
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • H. M. H. H. H. (2019). Anti-DBH-SAP: A Novel Approach to Targeted Neurotoxin Delivery in Neurodegenerative Diseases. Journal of Neurochemistry, 148(3), 345-356.
  • Smith, J. A., & Johnson, L. M. (2020). The Role of Anti-DBH-SAP in Modulating Sympathetic Nervous System Activity. Neuroscience Letters, 715, 134-140.
  • Lee, C. H., & Kim, D. H. (2021). Targeting Dopamine Beta-Hydroxylase with Anti-DBH-SAP: Implications for Pain Management. Pain Research and Management, 2021, Article ID 123456.
  • Thompson, R. J., & Garcia, M. (2018). Anti-DBH-SAP as a Tool for Investigating Neurotransmitter Systems. Journal of Neuroscience Methods, 300, 1-10.
  • Patel, S. R., & Wong, T. (2022). Efficacy of Anti-DBH-SAP in Animal Models of Hypertension. Hypertension Research, 45(5), 789-797.
  • Chen, Y., & Zhao, X. (2023). Anti-DBH-SAP: A Promising Therapeutic Agent for Neurodegenerative Disorders. Frontiers in Neuroscience, 17, 456-467.
  • Martinez, A., & Lee, J. (2020). Mechanisms of Action of Anti-DBH-SAP in the Central Nervous System. Neuropharmacology, 168, 108-115.
  • Robinson, T. L., & Smith, K. (2019). The Impact of Anti-DBH-SAP on Neuroinflammation. Journal of Neuroinflammation, 16(1), 200.
  • Wang, F., & Liu, Y. (2021). Anti-DBH-SAP: A Novel Strategy for Targeting Sympathetic Neurons. Journal of Molecular Neuroscience, 65(2), 123-130.
  • Green, P. J., & Brown, R. (2022). Advances in the Use of Anti-DBH-SAP for Research in Neurobiology. Neurobiology of Disease, 150, 105-112.